|
FR21C1059I2
(en)
|
|
PHARMACEUTICAL COMPOSITIONS
|
|
DK3030262T3
(en)
|
|
COMBINED PHARMACEUTICAL COMPOSITION
|
|
IL246377A0
(en)
|
|
Oral pharmaceutical composition
|
|
BR112016013333A2
(en)
|
|
oral care composition
|
|
EP3065716C0
(en)
|
|
FORMULATIONS
|
|
DK3079666T3
(en)
|
|
Pharmaceutical compositions comprising dimethyl fumarate
|
|
EP2953618A4
(en)
|
|
INVIOLABLE PHARMACEUTICAL FORMULATIONS
|
|
DK3287133T3
(en)
|
|
PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION
|
|
HUE036921T2
(en)
|
|
Oral deferasirox preparations
|
|
HRP20181607T1
(en)
|
|
STABLE ORAL SOLUTIONS FOR COMBINED ACTIVE PHARMACEUTICAL INGREDIENTS
|
|
DK2815752T3
(en)
|
|
ORAL PHARMACEUTICAL COMPOSITION
|
|
HUE066951T2
(en)
|
|
Pharmaceutical preparation containing phosphate-binding particles
|
|
DK3079655T3
(en)
|
|
INHALABLE MEDICINAL PRODUCTS
|
|
DK2964193T3
(en)
|
|
Oral administration drugs
|
|
SI2983650T1
(en)
|
|
Oral pharmaceutical composition comprising taste-masked n-acetylcysteine
|
|
SG11201509194SA
(en)
|
|
Radiomitigating pharmaceutical formulations
|
|
IL245705A0
(en)
|
|
Pharmaceutical dosage forms
|
|
HRP20181307T1
(en)
|
|
DENTAL PROCEDURE
|
|
DK3003401T3
(en)
|
|
PHARMACEUTICAL PREPARATION
|
|
EP2988734C0
(en)
|
|
HARD CAPSULE FORMULATION
|
|
BR112016002561A2
(en)
|
|
oral care implement
|
|
DK2897588T3
(en)
|
|
INHALABLE MEDICINAL PRODUCT
|
|
GB201305103D0
(en)
|
|
An oral dosage form
|
|
ZA201604100B
(en)
|
|
Gastro-retentive oral pharmaceutical compositions
|
|
HRP20171888T1
(en)
|
|
PHARMACEUTICAL PREPARATIONS
|